期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

套细胞淋巴瘤诊治新进展 被引量：6

下载PDF
导出
摘要 套细胞淋巴瘤（mantlecelllymphoma，MCL）是一种特殊的淋巴瘤亚型，兼具惰性淋巴瘤的难治愈性以及侵袭性特征。多见于老年，中位发病年龄58岁，男女比例约为2：1。中国抗癌协会淋巴瘤病理专家组统计了21127例淋巴瘤患者资料，MCL占非霍奇金淋巴瘤（Non-Hodgkin＇s Lymphoma，NHL）的5％。
作者 朱军 应志涛
机构地区 北京大学肿瘤医院 北京市肿瘤防治研究所淋巴肿瘤科
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第18期1067-1070,共4页 Chinese Journal of Clinical Oncology
关键词 套细胞淋巴瘤 诊断 治疗
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献27

  • 1Chandran R,Gardiner SK,Simon M,et al.Survival trends in mantle cell lymphoma in the United States over 16 years,1992-2007[J].J Clin Oncol,2011,29(Suppl):abstract e18530.
  • 2Fu K,Weisenburger DD,Greiner TC,et al.Cyclin D1-negative mantle cell lymphoma:a clinicopathology study based on gene expression profiling[J].Blood,2005,106(13):4315-4321.
  • 3Ek S,Dictor M,Jerkeman M,et al.Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma[J].Blood,2008,111(2):800-805.
  • 4Hoster E,Dreyling M,Klapper W,et al.A new prognostic index(MIPI) for patients with advanced-stage mantle cell lymphoma[J].Blood,2008,111(2):558-565.
  • 5Hoster E,Unterhalt M,Wommann B,et al.The addition of rituximab to first-line chemotherapy(R-CHOP) results in superior response rates,time to treatment failure and response duration in patients with advanced stage mantle cell lymphoma:long term results of a randomized GLSG trial[J].Blood,2008,112:16.
  • 6Dreyling MH,Griffiths R,Gleeson M,et al.Improved overall survival after the addition of rituximab to chemotherapy alone as first-line therapy for mantle cell lymphoma (MCL):Evidence from SEER-Medicare[J].J Clin Oncol,2011,29(Suppl):abstract e18500.
  • 7Balta A,Panitsas F,Skertsou M,et al.First line treatment with anthracycline-based regimen with or without rituximab in patients with mantle cell lymphoma[J].Ann Oncol,2011,22 Suppl 4:iv220.
  • 8Romaguera JE,Khouri IF,Kantarjian HM,et al.Untreated aggressive mantle cell lymphoma:results with intensive chemotherapy without stem cell transplant in elderly patients[J].Leuk Lymphoma,2000,39(1-2):77-85.
  • 9Merli F,Luminari S,Llariuvvi F,et al.Rituximab plus hyper CVAD alternating with high dose methotrexate and cytarabine for patients with newly diagnosed mantle cell lymphoma.A multicenter trial from GISL[J].Ann Oncol,2011,22 Suppl 4:iv162.
  • 10LaCase A,Vandergrift JL,Rodriguez MA,et al.R-CHOP,followed by high dose therapy and autologous stem cell rescue(HDT/ASCR),and R-HyperCVAD have equivalent progression-free survival and are superior to R-CHOP alone in younger patients with mantle cell lymphoma:a comparative effectiveness analysis from the National Comprehensive Cance Network(NCCN) Non-Hodgkin's Lymphoma Outcomes Database Project[J].Blood(ASH Annual Meeting Abstracts),2009,114:abstract 403.

同被引文献43

  • 1张莉,沈志祥.套细胞淋巴瘤治疗的现状[J].内科理论与实践,2007,2(1):61-63. 被引量：1
  • 2刘雪花,龚玉萍.套细胞淋巴瘤的研究进展[J].中华临床医师杂志(电子版).2013(20)
  • 3Fiona Cameron,Mark Sanford.Ibrutinib: First Global Approval[J].Drugs.2014(2)
  • 4Rekha Chandran,Stuart K. Gardiner,Miklos Simon,Stephen E. Spurgeon.Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007[J].Leukemia & Lymphoma.2012(8)
  • 5Sonmez M, ';:obanoglu 0, Karyagar S, et al. FDG-PET in mantle cell lymphoma involving skin [J]. Turk J Hematol, 2010, 27(4): 324-325.
  • 6Fu K, Weisenburger DD, Greiner TC, et al. Cyclin Dl-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling[J]. Blood, 2005, 106(13): 4315-4321.
  • 7Ek S, Dictor M, Jerkeman M, et al. Nuclear expression of the nonB-cell lineage Soxl1 transcription factor identifies mantle cell lymphoma[J]. Blood, 2008,111(2): 800-805.
  • 8Canpolat F, Tas E, Sonmez A A, et al. Cutaneous presentation of mantle cell lymphoma [J]. Acta Derm Venereol, 2010, 90 (5): 548-550.
  • 9Ishibashi M, Yamamoto K, Kudo S, et al. Mantle cell lymphoma with skin invasion characterized by the common variant in the subcutis and blastoid transformation in the overlying dennis [J]. Am J Dennatopathol, 2010, 32(2): 180-182.
  • 10Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classi- fication of lymphoid neoplasms and beyond : evolving concepts and practical applications[J]. Blood, 2011,117(19) :5019 -5032.

引证文献6

二级引证文献13

中国肿瘤临床
2011年 第18期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部